Annual Scientific Meeting of ASCEPT, 1999 From 'Captive' Agonism To Insurmountable Antagonism: Demonstrating The Power Of Analytical Pharmacology
- 5 March 2001
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 28 (3) , 223-229
- https://doi.org/10.1046/j.1440-1681.2001.03376.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Beyond EyeballingPublished by Taylor & Francis ,2000
- The Pharmacologic Consequences of Modeling Synoptic Receptor SystemsPublished by Taylor & Francis ,2000
- Introduction: Bioassays — Past Uses and Future PotentialPublished by Springer Nature ,2000
- Qualitative and quantitative assessment of relative agonist efficacyBiochemical Pharmacology, 1999
- Novel persistent activation of muscarinic M1 receptors by xanomelineEuropean Journal of Pharmacology, 1997
- Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer DiseaseArchives of Neurology, 1997
- Delirium in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1997
- A Personal View of PharmacologyAnnual Review of Pharmacology and Toxicology, 1996
- Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesJournal of Medicinal Chemistry, 1992
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982